IDEXX LaboratoriesFRA:IX1 +1.38%96 Pretax Margin % is 31.16% as of Mar. 2026, which is 25% above its 10-year median of 25.00. GuruFocus rates FRA:IX1 with a GF Score™ of 96/100 and a GF Value™ of €554.46 (Modestly Undervalued). Among 203 Medical Diagnostics & Research companies, IDEXX Laboratories ranks better than 97.54% on this metric.
The historical rank and industry rank for IDEXX Laboratories's Pretax Margin % or its related term are showing as below:
FRA:IX1'
s Pretax Margin % Range Over the Past 10 Years
Min: 18.13 Med: 25 Max: 30.8
Current: 30.8
FRA:IX1's Pretax Margin % is ranked better than 97.54% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.56
vs FRA:IX1: 30.80
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
IDEXX Laboratories Pretax Margin % Related Terms
IDEXX Laboratories Pretax Margin % Historical Data
* Premium members only.
The historical data trend for IDEXX Laboratories's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:IX1 vs A, WAT, NTRA: Pretax Margin % Comparison
For the Diagnostics & Research subindustry, IDEXX Laboratories's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories Pretax Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (FRA:IX1) has a Pretax Margin % of 31.16% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on IDEXX Laboratories and its competitors. This is 25% above median its historical median of 25.00. Over the past decade, IDEXX Laboratories' Pretax Margin % has ranged from 18.13 to 30.80. According to the industry distribution chart, IDEXX Laboratories ranks #5 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 2.5%.
Is IDEXX Laboratories' Pretax Margin % too high?
IDEXX Laboratories' current Pretax Margin % of 31.16% is 25% above median its 10-year median of 25.00. Over the past 10 years, this metric has ranged from a low of 18.13 to a high of 30.80. Based on the distribution chart, IDEXX Laboratories ranks #5 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Pretax Margin % compare to A and WAT?
According to the Medical Diagnostics & Research industry distribution chart, IDEXX Laboratories ranks #5 out of 203 companies for Pretax Margin %. This places IDEXX Laboratories in the top 3% of its industry — outperforming the majority of peers. Historically, IDEXX Laboratories' own Pretax Margin % has ranged from 18.13 to 30.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Pretax Margin % is 31.16%, which is 25% above median its own 10-year median of 25.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (FRA:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €554.46, compared to a current price of €484.70 — trading 12.6% below its estimated fair value. The current Pretax Margin % is 31.16%, which is 25% above median its 10-year median of 25.00. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For IDEXX Laboratories (FRA:IX1), the current Pretax Margin % is 31.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEXX Laboratories (FRA:IX1) Overvalued in 2026?
Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued.
The current stock price of €484.70 is trading 12.6% below its estimated GF Value™ of €554.46.
GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.
Key valuation signals for FRA:IX1:
Pretax Margin %: 31.16% (25% above median its 10-year median of 25.00)
GF Value™: €554.46 vs. price of €484.70 (12.6% below fair value)
No single metric tells the full story. See the FRA:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score
Get the complete analysis for FRA:IX1
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IX1 has been successfully added to your 
